摘要
目的:探讨阿立哌唑对老年精神分裂症治疗的疗效及安全性;方法:采用门诊开放性研究,对42例符CCMD-3精神分裂症或分裂样精神病的老年患者采用阿立哌唑10～20mg/d治疗,评价其有效性和安全性;结果:治疗2周后,PANSS阳性、阴性症状分和总分均显著下降(P<0.05);治疗过程中,无明显体重增加和心血管副反应;结论:阿立哌唑能有效缓解老年精神分裂症的精神病性症状,安全性高,适合于老年精神分裂症患者的治疗。
Objective: To investigate the efficacy and safety of Aripirazole in the treatment of Schizophrenia with.Methods: 42 patients in the study met the diagnostic criterion for Schizophrenia described in the CCMD-3.The dosage of Aripirazole varied from 10mg to 20mg.The efficacy and side effects were ussessed by PANSS,TESSand the changes of biochemical index and electrocardiogram.Results: The positive,negative subscores and total score decrease significantly(P < 0.05) after 2 week s treatment.During the treatme...
出处
《中国民族民间医药》
2009年第1期109-109,35,共1页
Chinese Journal of Ethnomedicine and Ethnopharmacy
